Combined Triple Therapy in Diabetic Retinopathy (DRP)

Sponsor
Johann Wolfgang Goethe University Hospital
Study ID
NCT00806169
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The aim of this pilot study was to investigate the effects of an intravitreal combination therapy using triamcinolone and bevacizumab in patients with macular edema due to diabetic retinopathy.

Key Dates

First listed
Dec 10, 2008
Start date
Apr 30, 2006
Status verified
Sep 2012
Primary completion
Oct 31, 2008
Completion
Nov 30, 2008

Study Design

Enrollment
40 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: 1
    group I (n=17) nonproliferative DR and ischemic maculopathy
  • Experimental: 2
    group II (n=38) nonproliferative DR without ischemic maculopathy
  • Experimental: 3
    group III (n=18) proliferative DR with or without ischemic maculopathy

Primary Outcome Measure

Best Corrected Visual Acuity [ Time Frame: Day of exam ]

Related Studies